Rich Pharmaceuticals, Inc. is pleased to announce the appointment of Professor Richard L. Chang to the Company’s Medical Advisory Board. Chang is the inventor and patent holder for indications presently being developed by Rich Pharmaceuticals. During his distinguished career, he has authored 121 peer-reviewed journal publications and has presented over 150 scientific abstracts across the world in the field of cancer research.
New Advances in Treating Hyperpigmentation
This past decade has seen an enormous surge in popularity of skin brightening products formulated specifically to treat hyperpigmentation and…

0 Comments